Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP‑9 signaling pathway in DU145 cells

Zeng,Yuan; Yang,Ying

doi:10.3892/mmr.2018.8653

Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP‑9 signaling pathway in DU145 cells

Authors:
- Yuan Zeng
- Ying Yang
View Affiliations

Affiliations: College of Life Sciences, Northwest University, Xi'an, Shaanxi 710069, P.R. China
Published online on: February 28, 2018 https://doi.org/10.3892/mmr.2018.8653
Pages: 6363-6370
Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Piperine, an alkaloid derived from natural products, has been demonstrated to exert antitumor activities in vivo and in vitro. However, its anti‑tumor effect has not yet been illustrated in the prostate cancer (PCa) metastatic process. Thus, the present study explored the influence of piperine on PCa and the underlying molecular mechanism. Cell migration was detected via the Transwell chamber model. Total protein was identified by western blot analysis. The data revealed that piperine markedly repressed cell proliferation and migration, and induced apoptosis in PCa DU145. In addition, LY294002, an protein kinase B (Akt) inhibitor, greatly suppressed the expression level of phospho (p)‑Akt, matrix metalloproteinase (MMP)‑9 and p‑mammalian target of rapamycin (mTOR), suggesting that the activation of the Akt/mTOR/MMP‑9 signaling pathway may participate in regulating cell migration in PCa. Furthermore, piperine reduced the expression of p‑Akt, MMP‑9 and p‑mTOR. Together, these data indicated that piperine may serve as a promising novel therapeutic agent to better overcome PCa metastasis.

View Figures

View References

1	Cooperberg MR and Chan JM: Epidemiology of prostate cancer. World J Urol. 35:8492017. View Article : Google Scholar : PubMed/NCBI
2	Shetty AV, Thirugnanam S, Dakshinamoorthy G, Samykutty A, Zheng G, Chen A, Bosland MC, Kajdacsy-Balla A and Gnanasekar M: 18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes. Int J Oncol. 39:635–640. 2011.PubMed/NCBI
3	Sharifi N, Gulley JL and Dahut WL: Androgen deprivation therapy for prostate cancer. JAMA. 294:238–244. 2005. View Article : Google Scholar : PubMed/NCBI
4	Pan H, Jansson KH, Beshiri ML, Yin J, Fang L, Agarwal S, Nguyen H, Corey E, Zhang Y, Liu J, et al: Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer. Oncotarget. 8:77181–77194. 2017. View Article : Google Scholar : PubMed/NCBI
5	Dias A, Kote-Jarai Z, Mikropoulos C and Eeles R: Prostate cancer germline variations and implications for screening and treatment. Cold Spring Harb Perspect Med. Nov 3–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
6	Chen Z, Zheng Y, Ji G, Liu X, Li P, Cai L, Guo Y and Yang J: Accuracy of dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate cancer: Systematic review and meta-analysis. Oncotarget. 8:77975–77989. 2017.PubMed/NCBI
7	Mittal R and Gupta RL: In vitro antioxidant activity of piperine. Methods Find Exp Clin Pharmacol. 22:271–274. 2000. View Article : Google Scholar : PubMed/NCBI
8	Pan H, Xu LH, Huang MY, Zha QB, Zhao GX, Hou XF, Shi ZJ, Lin QR, Ouyang DY and He XH: Piperine metabolically regulates peritoneal resident macrophages to potentiate their functions against bacterial infection. Oncotarget. 6:32468–32483. 2015. View Article : Google Scholar : PubMed/NCBI
9	Doucette CD, Greenshields AL, Liwski RS and Hoskin DW: Piperine blocks interleukin-2-driven cell cycle progression in CTLL-2 T lymphocytes by inhibiting multiple signal transduction pathways. Toxicol Lett. 234:1–12. 2015. View Article : Google Scholar : PubMed/NCBI
10	Sethiya NK, Shah P, Rajpara A, Nagar PA and Mishra SH: Antioxidant and hepatoprotective effects of mixed micellar lipid formulation of phyllanthin and piperine in carbon tetrachloride-induced liver injury in rodents. Food Funct. 6:3593–3603. 2015. View Article : Google Scholar : PubMed/NCBI
11	Toyoda T, Shi L, Takasu S, Cho YM, Kiriyama Y, Nishikawa A, Ogawa K, Tatematsu M and Tsukamoto T: Anti-inflammatory effects of capsaicin and piperine on helicobacter pylori-induced chronic gastritis in mongolian gerbils. Helicobacter. 21:131–142. 2016. View Article : Google Scholar : PubMed/NCBI
12	Sharma S, Kalia NP, Suden P, Chauhan PS, Kumar M, Ram AB, Khajuria A, Bani S and Khan IA: Protective efficacy of piperine against mycobacterium tuberculosis. Tuberculosis (Edinb). 94:389–396. 2014. View Article : Google Scholar : PubMed/NCBI
13	Greenshields AL, Doucette CD, Sutton KM, Madera L, Annan H, Yaffe PB, Knickle AF, Dong Z and Hoskin DW: Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett. 357:129–140. 2015. View Article : Google Scholar : PubMed/NCBI
14	Do MT, Kim HG, Choi JH, Khanal T, Park BH, Tran TP, Jeong TC and Jeong HG: Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chem. 141:2591–2599. 2013. View Article : Google Scholar : PubMed/NCBI
15	Zhang J, Sikka S, Siveen KS, Lee JH, Um JY, Kumar AP, Chinnathambi A, Alharbi SA, Basappa, Rangappa KS, et al: Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer. Apoptosis. 22:158–168. 2017. View Article : Google Scholar : PubMed/NCBI
16	Kou B, Liu W, He W, Zhang Y, Zheng J, Yan Y, Zhang Y, Xu S and Wang H: Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway. Oncol Rep. 35:2880–2886. 2016. View Article : Google Scholar : PubMed/NCBI
17	Berrak O, Arisan ED, Obakan-Yerlikaya P, Coker-Gürkan A and Palavan-Unsal N: mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Apoptosis. 21:1158–1178. 2016. View Article : Google Scholar : PubMed/NCBI
18	Deepak V, Kruger MC, Joubert A and Coetzee M: Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis. Biofactors. 41:403–413. 2015. View Article : Google Scholar : PubMed/NCBI
19	Doucette CD, Hilchie AL, Liwski R and Hoskin DW: Piperine, a dietary phytochemical, inhibits angiogenesis. J Nutr Biochem. 24:231–239. 2013. View Article : Google Scholar : PubMed/NCBI
20	Fofaria NM, Kim SH and Srivastava SK: Piperine causes G1 phase cell cycle arrest and apoptosis in melanoma cells through checkpoint kinase-1 activation. PLoS One. 9:e942982014. View Article : Google Scholar : PubMed/NCBI
21	Ouyang DY, Zeng LH, Pan H, Xu LH, Wang Y, Liu KP and He XH: Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy. Food Chem Toxicol. 60:424–430. 2013. View Article : Google Scholar : PubMed/NCBI
22	Samykutty A, Shetty AV, Dakshinamoorthy G, Bartik MM, Johnson GL, Webb B, Zheng G, Chen A, Kalyanasundaram R and Munirathinam G: Piperine, a bioactive component of pepper spice exerts therapeutic effects on androgen dependent and androgen independent prostate cancer cells. PLoS One. 8:e658892013. View Article : Google Scholar : PubMed/NCBI
23	Ai XL, Chi Q, Qiu Y, Li HY, Li DJ, Wang JX and Wang ZY: Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway. Mol Cell Biochem. 428:109–118. 2017. View Article : Google Scholar : PubMed/NCBI
24	He Q, Ren X, Chen J, Li Y, Tang X, Wen X, Yang X, Zhang J, Wang Y, Ma J and Liu N: miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways. Oncotarget. 7:3047–3058. 2016.PubMed/NCBI
25	Zhang D, Sun G, Zhang H, Tian J and Li Y: Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways. Biomed Pharmacother. 85:511–516. 2017. View Article : Google Scholar : PubMed/NCBI
26	Li C, Wang C, Xing Y, Zhen J and Ai Z: CD133 promotes gallbladder carcinoma cell migration through activating Akt phosphorylation. Oncotarget. 7:17751–17759. 2016.PubMed/NCBI
27	Selvaraj N, Budka JA, Ferris MW, Jerde TJ and Hollenhorst PC: Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation. Mol Cancer. 13:612014. View Article : Google Scholar : PubMed/NCBI
28	Marques RB, Aghai A, de Ridder CMA, Stuurman D, Hoeben S, Boer A, Ellston RP, Barry ST, Davies BR, Trapman J and van Weerden WM: High efficacy of combination therapy using PI3K/AKT inhibitors with androgen deprivation in prostate cancer preclinical models. Eur Urol. 67:1177–1185. 2015. View Article : Google Scholar : PubMed/NCBI
29	Chen H, Zhou L, Wu X, Li R, Wen J, Sha J and Wen X: The PI3K/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (Landmark Ed). 21:1084–1091. 2016. View Article : Google Scholar : PubMed/NCBI
30	Koutroulis I, Zarros A and Theocharis S: The role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: A chance for the development of targeted therapeutic approaches? Expert Opin Ther Targets. 12:1577–1586. 2008. View Article : Google Scholar : PubMed/NCBI
31	Khan MN, Choi JS, Lee MC, Kim E, Nam TJ, Fujii H and Hong YK: Anti-inflammatory activities of methanol extracts from various seaweed species. J Environ Biol. 29:465–469. 2008.PubMed/NCBI
32	Yaffe PB, Power Coombs MR, Doucette CD, Walsh M and Hoskin DW: Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Mol Carcinog. 54:1070–1085. 2015. View Article : Google Scholar : PubMed/NCBI